Euro Q1 Consumer Health Earnings Preview: Sanofi, Reckitt, GSK And Bayer
Major Europe-based consumer health players Sanofi, Reckitt, GSK and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q1 2022 results over the coming weeks.
You may also be interested in...
Reckitt’s VMS product sales exceeded expected 4% to 5% Q1 growth due to strong sales in China. Company also increased 2022 guidance due to a strong start.
Reckitt Benckiser has committed to transferring ownership of its operations in Russia following the country's invasion of Ukraine in February.
Bayer Consumer Health posted sales up 6.5% in 2021 as strong demand for supplements and successful launches helped it grow faster than the global market. The company believes it can deliver up to 5% sales growth in 2022 driven by the upcoming launch of Astepro Allergy in the US and the return of the cough & cold category.